Wegovy, a new medication used to treat obesity, may offer an additional unexpected benefit
Ikoma N, Estrella JS, Hofstetter W , Das P, Minsky BD, Ajani JA, Fournier KF, Mansfield P, Badgwell BD
Allowing the liver enough time to metabolize the alcohol is the only way to remove alcohol from the body
These drugs induce a mean weight loss of 1.88kg and also lower blood pressure (mean: 2.46mmHg in systolic and 1.46mmHg in diastolic blood pressure).48 The EMPA-REG,49 CANVAS and CANVAS-R trials,50 conducted in patients with DM2 and high cardiovascular risk, showed empagliflozin and canagliflozin to reduce cardiovascular risk (including cardiovascular death, non-fatal myocardial infarction or non-fatal stroke, and hospital admission due to heart failure)
This chart covers the Zepbound weight management indication